To analyze the clinicopathological characteristics and prognostic factors of HER2‐low BC patients, we collected and analyzed the clinicopathological data of HER2‐low early‐stage breast cancer (EBC) patients treated at the Breast Disease Center of Peking University First Hospital from January 2014 to December 2017. The gene discussed is ERBB2; the disease is breast cancer.